EGFR and metastatic colorectal cancer: The standard systemic medication for metastatic colorectal cancer and metastatic gastrointestinal cancer includes cytotoxic drugs (for example, oxaliplatin or bevacizumab) and/or targeted agents (anti-VEGFR, anti-EGFR antibodies).